(Q34730353)

4 August 2017

title

Pre-clinical and Clinical Safety Studies of CMX-2043: a cytoprotective lipoic acid analogue for ischaemia-reperfusion injury (English)

1 reference

4 August 2017

1 reference

Steven A Kates

1

1 reference

4 August 2017

Alan S Lader

series ordinal

2

1 reference

4 August 2017

Ralph Casale

series ordinal

3

1 reference

4 August 2017

Reinier Beeuwkes

series ordinal

4

1 reference

4 August 2017

publication date

16 May 2014

1 reference

Basic and Clinical Pharmacology and Toxicology

4 August 2017

published in

1 reference

4 August 2017

volume

115

1 reference

4 August 2017

issue

5

1 reference

4 August 2017

page(s)

456-464

1 reference

Lipoic acid analogs with enhanced pharmacological activity

4 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Efficacy and safety of alpha-lipoic acid supplementation in the treatment of symptomatic diabetic neuropathy

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Lipoic acid - the drug of the future?

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Myocardial ischemia and reperfusion injury

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Lipoic acid is 10 times more toxic in cats than reported in humans, dogs or rats

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Treatment of symptomatic diabetic polyneuropathy with the antioxidant alpha-lipoic acid: a meta-analysis

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Plasma Kinetics, Metabolism, and Urinary Excretion of Alpha‐Lipoic Acid following Oral Administration in Healthy Volunteers

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

The pharmacology of the antioxidant lipoic acid

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Alpha-lipoic acid as a biological antioxidant

7 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Alpha-lipoic acid improves vascular endothelial function in patients with type 2 diabetes: a placebo-controlled randomized trial

7 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12254

Safety evaluation of alpha-lipoic acid (ALA).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12254

Long-term safety of alpha-lipoic acid (ALA) consumption: A 2-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12254

Oral administration of RAC-alpha-lipoic acid modulates insulin sensitivity in patients with type-2 diabetes mellitus: a placebo-controlled pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12254

Pharmacokinetics of alpha-lipoic acid in subjects with severe kidney damage and end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12254

Lipoic acid in multiple sclerosis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12254

Lipoic acid acutely induces hypoglycemia in fasting nondiabetic and diabetic rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FBCPT.12254

International Conference on Harmonisation; guidance on S7B Nonclinical Evaluation of the Potential for Delayed Ventricular Repolarization (QT Interval Prolongation) by Human Pharmaceuticals; availability. Notice.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4270215

Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant alpha-lipoic acid. A 3-week multicentre randomized controlled trial (ALADIN Study)

26 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24751172

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Insulin Autoimmune Syndrome possibly caused by alpha lipoic acid

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/24751172

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1111/BCPT.12254

1 reference

4 August 2017

1 reference

4 August 2017

1 reference